ESCITALOPRAM ORAL SOLUTION
Generic: ESCITALOPRAM ORAL
Chartwell RXManufacturer
ORALRoute
ESCITALOPRAM OXALATEActive Substance
2013-06-12Original Approval
ESCITALOPRAM ORAL SOLUTION is FDA application ANDA090477, sponsored by CHARTWELL MOLECULAR. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG INEFFECTIVE
4,979 reports
2
FATIGUE
4,721 reports
3
NAUSEA
4,462 reports
4
OFF LABEL USE
4,020 reports
5
HEADACHE
3,851 reports
6
DIARRHOEA
3,828 reports
7
DIZZINESS
3,177 reports
8
DRUG INTERACTION
3,150 reports
9
FALL
3,140 reports
10
ANXIETY
3,057 reports